Skip to main content
logo
GC Cell Corporation (KOSDAQ:144510)
South Korea flag South Korea · Delayed Price · Currency is KRW
23,100
+250 (1.09%)
Apr 10, 2026, 3:30 PM KST

Revenue by Segment

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Other
2.18B1.31B1.14B362.68M391.96M
Other Growth
65.70%14.83%215.44%-7.47%282.90%
Cell Therapy
13.80B6.58B7.92B1.91B-
Cell Therapy Growth
109.52%-16.87%313.85%--
Biologistics
25.82B19.24B12.21B9.60B4.07B
Biologistics Growth
34.23%57.59%27.16%135.74%-17.42%
Cell Storage
2.51B1.94B1.43B958.28M1.08B
Cell Storage Growth
29.55%35.22%49.44%-11.50%-35.21%
Product Sales
8.40B7.26B5.83B4.53B3.18B
Product Sales Growth
15.59%24.59%28.77%42.56%53.85%
CDMO
5.71B7.68B492.27M--
CDMO Growth
-25.67%1461.09%---
Immuno-Anticancer Drug
34.94B30.67B6.28B--
Immuno-Anticancer Drug Growth
13.91%388.41%---
Acceptance of Specimen Service
94.19B161.43B133.00B68.20B43.64B
Acceptance of Specimen Service Growth
-41.65%21.37%95.02%56.30%15.42%
Clinical Consignment
----5.54B
Clinical Consignment Growth
----36.89%
Total
187.54B236.12B168.31B85.56B57.90B
Total Growth
-20.57%40.29%96.71%47.79%14.37%

Revenue by Geography

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Overseas
----192.75M
South Korea
165.21B219.41B159.48B83.27B57.70B
South Korea Growth
-24.70%37.58%91.51%44.31%-
Japan
1.54B1.26B335.39M71.32M-
Japan Growth
22.35%274.75%370.26%--
Other
666.99M1.73B-4.56M-
Other Growth
-61.55%----
USA
20.13B13.72B8.50B2.22B-
USA Growth
46.72%61.38%283.70%--
Total
187.54B236.12B168.31B85.56B57.90B
Total Growth
-20.57%40.29%96.71%47.79%-
Source: S&P Global Market Intelligence.